FIELD: chemistry.
SUBSTANCE: present invention relates to combinations of GPR119 receptor agonists with DPP-4 inhibitors, as well as to the use of these combinations.
EFFECT: treatment or prevention of cardiovascular disorders and metabolic disorders, including diabetes mellitus, non-alcoholic fatty liver disease (NAFLD), NAFL, NASH, dyslipidaemia and related disorders.
12 cl, 6 ex, 2 dwg
| Title |
Year |
Author |
Number |
| METHOD OF IMPROVEMENT OF LIVER FUNCTION |
2013 |
- Uolder Ken
- Krippner Gaj
- Nikolson Dzhoff
|
RU2653478C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHOEPATITIS |
2021 |
- Kim, Mi-Kyung
- Park, Hansu
- Lee, Seung Ho
|
RU2803733C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DIABETES AND RELATED METABOLIC DISEASES |
2021 |
- Kim, Mi-Kiung
- Kim, Tae Khioung
- Dzung, Ii Khoon
- Chae, Yu Na
- Yang, Dzae Sung
|
RU2809286C1 |
| FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE |
2020 |
- Dun, Chzhao
- Chzhou, Chi
- Chzhan, Tsziyu
- Li, Yuanli
- Li, Tsyan
|
RU2804335C2 |
| PHARMACEUTICAL COMBINATION COMPRISING IBAT-INHIBITOR AND BILE ACID BINDER |
2011 |
- Jillberg Per-Jeran
- Graffner Khans
- Starke Ingemar
|
RU2619215C2 |
| COMBINATION FOR REGENERATIVE THERAPY OF TYPE 1 DIABETES MELLITUS |
2018 |
|
RU2694527C1 |
| APPLICATION OF DPP-IV INHIBITOR FOR REDUCTION OF GLYCEMIA ACUTE EXACERBATION |
2006 |
- Bal'Kan Berk
- Kholms Dejvid Grenvill
- Kh'Juz Tomas Ehduard
- Villkhoer Ehduin Bernard
|
RU2440143C2 |
| COMBINATION OF OMEGA-3 FATTY ACID AND SGLT-2 INHIBITOR FOR TREATING LIVER DISEASES |
2015 |
- Gannedahl Karl Erik Goeran
|
RU2695652C2 |
| SITAGLIPTIN TANNATE COMPLEX |
2015 |
- Omwancha, Wycliffe
- Burlage, Rubi
|
RU2696588C2 |
| METHOD OF TREATING HEPATIC FIBROSES |
2017 |
|
RU2740902C2 |
